Literature DB >> 20606756

The role of proteomics in plasma fractionation and quality control of plasma-derived therapeutic proteins.

Dajana Gaso-Sokac1, Djuro Josic.   

Abstract

Keywords:  Factor VIII; plasma fractionation; proteomics; quality control

Mesh：

Substances：

Year:  2010        PMID： 20606756      PMCID： PMC2897198          DOI： 10.2450/2010.014S

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  29 in total

Review 1.  Preparation of vitamin K-dependent proteins, such as clotting factors II, VII, IX and X and clotting inhibitor protein C.

Authors:  Djuro Josic; Lutz Hoffer; Andrea Buchacher
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2003-06-25       Impact factor: 3.205

Review 2.  Issues in the development of medical products based on human plasma.

Authors:  D Josić; P Schulz; L Biesert; L Hoffer; H Schwinn; M Kordis-Krapez; A Strancar
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1997-07-04

3.  Properties of a highly purified human plasma factor IX:c therapeutic concentrate prepared by conventional chromatography.

Authors:  T Burnouf; C Michalski; M Goudemand; J J Huart
Journal:  Vox Sang       Date:  1989       Impact factor: 2.144

4.  Human pre-alpha-inhibitor: isolation from a by-product of industrial scale plasma fractionation and structural analysis of its H3 heavy chain.

Authors:  C Mizon; A Héron; C Capon; P Sautiere; C Michalski; R Sesboüé; J Mizon
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1997-05-09

5.  Anticomplementary activity of IVIG concentrates--important assay parameters and impact of IgG polymers.

Authors:  A Buchacher; P Schluga; J Müllner; M Schreiner; C Kannicht; J Weinberger
Journal:  Vox Sang       Date:  2010-04       Impact factor: 2.144

6.  On the variation of glycosylation in human plasma derived antithrombin.

Authors:  Uwe M Demelbauer; Alexander Plematl; Djuro Josic; Günter Allmaier; Andreas Rizzi
Journal:  J Chromatogr A       Date:  2005-07-01       Impact factor: 4.759

7.  Vitronectin in clotting factor IX concentrates.

Authors:  D Josic; C Kannicht; K Löster; K Pock; G Iberer; A Buchacher
Journal:  Haemophilia       Date:  2001-05       Impact factor: 4.287

8.  Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents.

Authors:  Philip L Ross; Yulin N Huang; Jason N Marchese; Brian Williamson; Kenneth Parker; Stephen Hattan; Nikita Khainovski; Sasi Pillai; Subhakar Dey; Scott Daniels; Subhasish Purkayastha; Peter Juhasz; Stephen Martin; Michael Bartlet-Jones; Feng He; Allan Jacobson; Darryl J Pappin
Journal:  Mol Cell Proteomics       Date:  2004-09-22       Impact factor: 5.911

9.  Fragmentation of therapeutic human immunoglobulin preparations.

Authors:  M Page; C Ling; P Dilger; M Bentley; T Forsey; C Longstaff; R Thorpe
Journal:  Vox Sang       Date:  1995       Impact factor: 2.144

10.  In vitro study of a triple-secured von Willebrand factor concentrate.

Authors:  C Mazurier; M Poulle; B Samor; L Hilbert; S Chtourou
Journal:  Vox Sang       Date:  2004-02       Impact factor: 2.144
View more
  1 in total

1.  Prioritization of biomarker targets in human umbilical cord blood: identification of proteins in infant blood serving as validated biomarkers in adults.

Authors:  Nicole Hansmeier; Tzu-Chiao Chao; Lynn R Goldman; Frank R Witter; Rolf U Halden
Journal:  Environ Health Perspect       Date:  2012-01-27       Impact factor: 9.031
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.